BRIEF-U.S. FDA approves Zinbryta to treat multiple sclerosis By: Reuters: Company News May 27, 2016 at 18:17 PM EDT * Zinbryta has a boxed warning & is available only through a restricted distribution program under a risk evaluation and mitigation strategy Read More >> Related Stocks: Biogen Idec